Nothing Special   »   [go: up one dir, main page]

DE69328492D1 - Fettsäure-derivate und diese enthaltende pharmazeutische präparationen - Google Patents

Fettsäure-derivate und diese enthaltende pharmazeutische präparationen

Info

Publication number
DE69328492D1
DE69328492D1 DE69328492T DE69328492T DE69328492D1 DE 69328492 D1 DE69328492 D1 DE 69328492D1 DE 69328492 T DE69328492 T DE 69328492T DE 69328492 T DE69328492 T DE 69328492T DE 69328492 D1 DE69328492 D1 DE 69328492D1
Authority
DE
Germany
Prior art keywords
fatty acid
acid derivatives
pharmaceutical preparations
preparations containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69328492T
Other languages
English (en)
Other versions
DE69328492T2 (de
Inventor
A Devane
Raphael Mechoulam
Aviva Beuer
Lumir Hanus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Application granted granted Critical
Publication of DE69328492D1 publication Critical patent/DE69328492D1/de
Publication of DE69328492T2 publication Critical patent/DE69328492T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69328492T 1992-11-30 1993-11-30 Fettsäure-derivate und diese enthaltende pharmazeutische präparationen Expired - Fee Related DE69328492T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL10393292A IL103932A (en) 1992-11-30 1992-11-30 Fatty acid and pharmaceutical compositions containing them
PCT/US1993/011625 WO1994012466A1 (en) 1992-11-30 1993-11-30 Fatty acid derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
DE69328492D1 true DE69328492D1 (de) 2000-05-31
DE69328492T2 DE69328492T2 (de) 2000-09-07

Family

ID=11064282

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328492T Expired - Fee Related DE69328492T2 (de) 1992-11-30 1993-11-30 Fettsäure-derivate und diese enthaltende pharmazeutische präparationen

Country Status (13)

Country Link
EP (1) EP0670826B1 (de)
JP (1) JPH08504195A (de)
CN (1) CN1097735A (de)
AU (1) AU5733494A (de)
CZ (1) CZ136195A3 (de)
DE (1) DE69328492T2 (de)
ES (1) ES2145118T3 (de)
HU (1) HUT73177A (de)
IL (1) IL103932A (de)
PL (1) PL309051A1 (de)
SK (1) SK70895A3 (de)
WO (1) WO1994012466A1 (de)
ZA (1) ZA938947B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
AU3124995A (en) * 1994-07-11 1996-02-09 Kristiina Jarvinen Anandamide analogue compositions and method of treating intraocular hypertention using same
IT1271267B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
DE19544635A1 (de) * 1995-11-30 1997-06-05 Boehringer Mannheim Gmbh Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19706903A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
DE69911755T2 (de) 1998-04-03 2004-08-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Synthetische endogene cannabinoidanaloge und ihre verwendungen
EP1645270B1 (de) * 1998-05-29 2010-04-28 Neurosciences Research Foundation Inc. Schmerzlinderung mit anandamide
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
AU5198199A (en) 1998-08-17 2000-03-06 Senju Pharmaceutical Co., Ltd. Preventives/remedies for glaucoma
WO2000032200A1 (en) * 1998-11-24 2000-06-08 Alexandros Makriyannis Cannabimimetic lipid amides as useful medications
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
AU2001264930A1 (en) 2000-05-23 2001-12-03 The Regents Of The University Of California A novel treatment for cough
NO20006008L (no) 2000-11-28 2002-05-29 Thia Medica As Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
JP2004526745A (ja) 2001-03-27 2004-09-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 体脂肪を減らし脂肪酸の代謝を変調する方法、化合物および組成物
WO2003008632A1 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Fatty acid conjugation as a method for screening of potentially bioactive substances
WO2003075917A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
EP1509250B1 (de) 2002-06-06 2008-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Verfahren, zusammensetzungen und herstellungsgegenstände zur modulierung des knochenwachstums
ITMI20030210A1 (it) * 2003-02-07 2004-08-08 Res & Innovation Soc Coop A R L Composti endocannabinoido-simili e loro impiego
EP1644335A4 (de) 2003-07-11 2008-06-04 Bristol Myers Squibb Co Tetrahydrochinolinderivate als modulatoren des cannabinoidrezeptors
US7326706B2 (en) 2003-08-15 2008-02-05 Bristol-Myers Squibb Company Pyrazine modulators of cannabinoid receptors
IL160420A0 (en) 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
AU2007248760A1 (en) * 2006-05-01 2007-11-15 Eastern Virginia Medical School Novel cannabinoids and methods of use
WO2008139263A2 (en) * 2006-11-30 2008-11-20 University Of Plymouth Methods for slowing the progression of multiple sclerosis
CN101815697A (zh) 2007-07-30 2010-08-25 奥特兰兹公司 大麻二酚前药、包括大麻二酚前药的组合物及其使用方法
EP2262763A2 (de) 2008-03-04 2010-12-22 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Verbindungen und verfahren zur behandlung von obesitas
WO2010013240A1 (en) * 2008-07-31 2010-02-04 Dekel Pharmaceuticals Ltd. Compositions and methods for treating inflammatory disorders
WO2011066414A1 (en) * 2009-11-25 2011-06-03 Cytometix, Inc. Arachidonic acid analogs and methods for analgesic treatment using same
CN103877100B (zh) * 2013-05-21 2016-08-10 成都旗美健康食品有限公司 亚麻酸酰基乙醇胺的联合医用和保健用药物
EP3955747A4 (de) * 2019-04-15 2023-02-01 Metagenics, Inc. Neuartige hanf- und erbsenformulierung und deren verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE306730B (de) * 1963-02-06 1968-12-09 Sumitomo Chemical Co
SE353319B (de) * 1964-08-15 1973-01-29 Sumitomo Chemical Co
US4619938A (en) * 1984-03-21 1986-10-28 Terumo Kabushiki Kaisha Fatty acid derivatives of aminoalkyl nicotinic acid esters and platelet aggregation inhibitors
NZ216751A (en) * 1985-07-05 1990-01-29 Cird Eicosatriynoic acid esters and amides,pharmaceutical compositions and process for preparing eicosatriynoic acid

Also Published As

Publication number Publication date
ZA938947B (en) 1994-08-02
DE69328492T2 (de) 2000-09-07
IL103932A (en) 1997-02-18
HU9501561D0 (en) 1995-07-28
EP0670826A4 (de) 1996-08-14
CZ136195A3 (en) 1995-11-15
CN1097735A (zh) 1995-01-25
HUT73177A (en) 1996-06-28
JPH08504195A (ja) 1996-05-07
PL309051A1 (en) 1995-09-18
SK70895A3 (en) 1995-09-13
IL103932A0 (en) 1993-04-04
AU5733494A (en) 1994-06-22
WO1994012466A1 (en) 1994-06-09
ES2145118T3 (es) 2000-07-01
EP0670826B1 (de) 2000-04-26
EP0670826A1 (de) 1995-09-13

Similar Documents

Publication Publication Date Title
DE69328492D1 (de) Fettsäure-derivate und diese enthaltende pharmazeutische präparationen
PT81969A (de) 11beta-phenyl-gonane deren herstellung und diese enthaltende pharmazeutische praparate
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
DE69124721D1 (de) Carbostyrilderivate und diese enthaltende pharmazeutische Zusammensetzungen
PT78732B (de) 13-alpha-alkylgonane deren herstellung und diese enthaltende pharmazeutische praeparate
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE69429821D1 (de) Farnesyl-derivate und diese enthaltende arzneimittel
DE69409969D1 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
IT1243541B (it) Dispositivo di somministrazione in particolare di sostanza farmaceutica
DK481989D0 (da) Farmaceutiske formuleringer
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
DE59813619D1 (de) Ascorbinsäurederivate enthaltende kosmetische und pharmazeutische Zubereitungen
DE69320242D1 (de) Medizinische Selbstklebefolie und Arzneimittelzubereitung
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
DE59604457D1 (de) Zuckertenside und Fettsäurepartialglyceride enthaltende kosmetische und/oder pharmazeutische Zubereitungen
ITMI921413A0 (it) Preparazioni farmaceutiche stabili di nicorandil
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3481125D1 (de) Pheophorbidderivate und diese enthaltende pharmazeutische mittel.
DE69323568D1 (de) Antimikrobielle Zusammensetzungen und pharmazeutische Präparate hiervon
DK269289D0 (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
DE69800970D1 (de) Pyridinderivate und sie enthaltende pharmazeutische zubereitungen
DE69018914D1 (de) Pharmakologisch aktive Präparate und sie enthaltende Arzneimittel.
NO951933D0 (no) Farmasöytiske formuleringer av ibuprofen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee